Bioventus Inc. (BVS) Misses Q2 EPS by 6c; Offers FY22 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
Tweet
Share
E-mailGet Alerts BVS Hot Sheet
Join SI Premium – FREE
Bioventus Inc. (NASDAQ: BVS) reported Q2 EPS of $0.10, $0.06 worse than the analyst estimate of $0.16. Revenue for the quarter came in at $140.3 million versus the consensus estimate of $138.33 million.
GUIDANCE:
Bioventus Inc. sees FY2022 EPS of $0.47-$0.57, versus the consensus of $0.65. Bioventus Inc. sees FY2022 revenue of $547.5-562.5 million, versus the consensus of $552 million.
For earnings history and earnings-related data on Bioventus Inc. (BVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Netflix shares fall over 5% premarket on soft current-quarter revenue guidance
- Winnebago Industries (WGO) Misses Q4 EPS by 2c; offers guidance
- Alaska Air Group (ALK) Tops Q3 EPS by 8c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
